Track topics on Twitter Track topics that are important to you
Aptuit, Inc. is a global pharmaceutical services company focused on delivering contract development and manufacturing services and streamlining the drug development process for biotechnology and pharmaceutical innovators. Aptuitâs employees deliver an integrated suite of product development services to more than 800 companies worldwide, driven by a deep commitment to client service, quality, and an unrivaled track record of scientific excellence. The company is partnered with Welsh, Carson, Anderson & Stowe, one of the worldâs leading private equity investors. For more information about Aptuit, please visit www.aptuit.com, for more information about Aptuitâs acquisition of the Verona Medicines Research Centre operations, please visit http://www.aptuit.com/Verona.
Three Greenwich Office Park
United States of America
Phone: 1 203 422 6600
Fax: 1 203 422 0266
Evotec and Aptuit announced that they have entered into a definitive agreement under which Evotec will acquire Aptuit for $300 million. This transaction will strengthen Evotec’s position as the ...
Evotec AG akquiriert Aptuit DGAP-Ad-hoc: Evotec AG / Schlagwort(e): Firmenübernahme Evotec AG akquiriert Aptuit 30.07.2017 / 18:45 CET/CEST Veröffentlichung einer Insiderinformation gemäß Artikel ...
Aptuit has been acquired by Evotec for $300 million. The deal is expected to close in the third quarter of this year. -More-
Evotec has completed its previously announced acquisition of Aptuit and has updated its financial targets for the year.
Die Ende Juli bekannt gewordene Übernahme von 100% des ausgegebenen und ausstehenden Anteilsbesitzes von Aptuit begleicht das Unternehmen durch bestehende Liquiditätsreserven und eine zusätzliche n...
German company Evotec has completed the acquisition of Aptuit for a total consideration of approximately $300m to support its long-term strategy to be the industry partner of choice for external drug ...
German small molecule drugs developer Evotec has agreed to acquire pharmaceutical services company Aptuit for $300m from private equity firm Welsh, Carson, Anderson & Stowe (WCAS).
Evotec's CEO tells Scrip that by buying the CRO Aptuit his combined group becomes a one-stop-shop for drug makers who...
Aptuit, Inc. is a global pharmaceutical services company focused on delivering contract development and manufacturing services and streamlining the drug development process for bi...
Aptuit Informatics (formerly InfoPro Solutions) was acquired by Aptuit Inc. and is one of five business lines operating under the Aptuit umbrella. Download the Aptuit Corporate Fact Sheet (PDF). Aptui...
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovato...
We have published hundreds of Aptuit, Inc. news stories on BioPortfolio along with dozens of Aptuit, Inc. Clinical Trials and PubMed Articles about Aptuit, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptuit, Inc. Companies in our database. You can also find out about relevant Aptuit, Inc. Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...